Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fezolinetant for Vasomotor Symptoms in Menopause
NCT06812754Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fezolinetant in hot flashes, sponsored by Astellas Pharma. Started Mar 2025; status: completed.
02
Drugs
fezolinetant
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT06812754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06812754.